Summary&horbar;This study measured glycosaminoglycans (GAGs) in human follicular fluid (hFF) obtained from patients undergoing hormonal stimulation with combined GnRH agonist followed by gonadotropin hormone (hMG or FSH) for in vitro fertilization (IVF). The GAGs were partially characterized through the use of various mucopolysaccharidases and then their effects tested on human sperm motility. In hFF, the GAG and protein concentrations were 4.4 ± 1.3 mg/L and 32.6 ± 3.2 g/L respectively. Chondroitins (CS) and hyaluronic acid (HA) significantly stimulate sperm motion in comparison to the control. The oocytes inseminated with GAGs-pretreated spermatozoa showed a significantly higher rate of cleavage and pregnancy or delivered number. The present results suggest that hFF is a rich source of sulfated glycosaminoglycan (CS), and non-sulfated glycosaminoglycan (HA). The 
INTRODUCTION
To fertilize the oocyte, spermatozoa must undergo a series of changes during capacitation and the acrosome reaction, which lead to the expression of their fertilizing ability. These processes, which usually take place in the female genital tract, are characterized by surface alterations in the membrane proteins, membrane component fluidity, cyclic adenosine monophosphate (AMPc) levels, and hyperactivation of spermatozoa (Yanagimachi, 1988) . Some biological fluids, ie, serum (Makler et al, 1984) , peritoneal fluid (Soldati et al, 1989) and follicular fluid (Tesarik, 1985; Suarez et al, 1986; Hamamah et al, 1995) , have been proposed to stimulate sperm motility. Many studies have provided evidence for a positive effect by human follicular fluid (hFF), based on the changes in spermatozoa motility (Mbizvo et al, 1990 ; Mendoza and Tesarik, 1990; Siegel et al, 1990) . These include an increase in the penetration rate in the hamster egg penetration test (Yee and Cummings, 1988) as well as in the fertilization rate of in vitro human fertilization (Ghetler et al, 1990) . Hyperactivation, also observed after hFF treatment, has been described for human spermatozoa as well as other species. Such a phenomenon has been well documented, especially in hamster sperm (Suarez et al, 1991 (Lenz et al, 1982; Eriksen et al, 1991 
Preparation of hFF after enzyme hydrolysis
Individual hFF (n = 8) was diluted 1:10 in 1 M sodium acetate buffer containing 1.5 M NaCI (pH 7.3), and divided into four aliquots. One aliquot was used as a control and the others were enriched with hyaluronidase (HYase), chondroitinase ABC (ABCase), and chondroitinase AC (ACase), at the rate of 50, 0.5, and 0.5 mU, respectively, in 800 pL of hFF. The samples were incubated for 16 h at 37 °C. Inactivation of the enzyme was undertaken using a 100 °C water bath for 1 min. The samples, including the control, were frozen-thawed. After thawing the samples were incubated with 1 mg of pronase for 800 pL hFF under similar conditions and the enzyme activity was stopped as above. All (Triana et al, 1980) . However, Osman et al (1989) Lenz et al, 1983; Bushmeyer et al, 1985; Eriksen et al, 1994) . On the other hand, in human sperm, HA has been shown to induce capacitation (Karlstrom et al, 1991) and to maintain the sperm motility (Huazar et al, 1990 (Drahorad et al, 1991; Ball et al, 1982, respectively). Although Hurst et al (1989) demonstrated that the bovine sperm surface contains receptors that are specific for glycosaminoglycans, the origin of GAGs in hFF remains as yet unknown. It is possible that the GAGs from hFF may be transported from the cumulus-oophorus oocytes cells to the follicular fluid via the granulosa cells.
The percentage of cycles with embryo replacement was high in the treated group in comparison with controls. The implantation rate was high for the embryos of the treated group in spite of the fact that the mean number of embryos transferred was similar in the two groups. The improved cleavage rate and particularly the ongoing pregnancy rate or delivered number was high in the treated group in comparison with controls. While it is difficult to propose a valid explanation for these results, this study suggested that the pretreatment of spermatozoa with GAG may produce better embryos to be transferred or involved in the implantation process. However, Hook et al (1984) reported that GAGs may exert their influence on cell behavior via an effect on cell-to-cell adhesion.
Recently, Hemmings et al (1994) reported that the hFF supplementation under IVF conditions has been associated with a significantly higher proportion of pre-embryos reaching the morula and blastocyste stage.
As follicular fluid contains many of the growth factors that have been involved in early mammalian embryo development the currently accepted idea is that growth factors bind or interact with GAGs to exert a cell proliferation effect (Sato et al, 1991) . However, the molecular basis for the action by which GAGs promote embryonic development remains to be determined.
